Prognostic Impact of Psoas Muscle Mass Index following Trans-Catheter Aortic Valve Replacement
Journal of Clinical Medicine · 09.06.2023 · 12 (12) · 3943
DOI: 10.3390/jcm12123943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.06.2023. Verfasst von Teruhiko Imamura und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Psoas muscle mass is a recently featured index of sarcopenia, which has a negative prognostic impact in patients with a variety of diseases. We investigated the prognostic impact of baseline psoas muscle mass in patients receiving a trans-catheter aortic valve replacement (TAVR).
Methods
Patients who received TAVR at our center between 2015 and 2022 were included. Patients received computer tomography imaging upon admission as an institutional protocol, and psoas muscle mass was measured, which was indexed by body surface area. Patients were followed for four years or until January 2023. The prognostic impact of psoas muscle mass index on 4-year mortality following index discharge was evaluated.
Results
A total of 322 patients (85 years, 95 male) were included. Median psoas muscle mass index at baseline was 10.9 (9.0, 13.5) × 10 cm3/m2. A lower psoas muscle mass index tended to be associated with several index of malnutrition and sarcopenia. A psoas muscle mass index was independently associated with 4-year mortality with an adjusted hazard ratio of 0.88 (95% confidence interval 0.79–0.99, p = 0.044). Patients with lower psoas muscle mass index (below the statistically calculated cutoff of 10.7 × 10 cm3/m2, N = 152) had significantly higher cumulative 4-year mortality compared with others (32% versus 13%, p = 0.008).
Conclusions
A lower psoas muscle mass index, which is a recently featured objective marker of sarcopenia, was associated with mid-term mortality following TAVR in the elderly cohort with severe aortic stenosis. The measurement of psoas muscle mass index prior to TAVR could have clinical implications for shared decision-making among patients, their relatives, and clinicians.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.
ORCID-Profile: Teruhiko Imamura, Hiroshi Ueno
Zitieren
APA
Imamura, T., Fujioka, H., Ushijima, R., Sobajima, M., Fukuda, N., Ueno, H., & Kinugawa, K. (2023). Prognostic Impact of Psoas Muscle Mass Index following Trans-Catheter Aortic Valve Replacement. Journal of Clinical Medicine, 12(12), 3943. https://doi.org/10.3390/jcm12123943
Vancouver
Imamura T, Fujioka H, Ushijima R, Sobajima M, Fukuda N, Ueno H, et al. Prognostic Impact of Psoas Muscle Mass Index following Trans-Catheter Aortic Valve Replacement. Journal of Clinical Medicine. 2023;12(12):3943. doi:10.3390/jcm12123943
BibTeX
@article{Imamura2023,
author = {Imamura, Teruhiko and Fujioka, Hayato and Ushijima, Ryuichi and Sobajima, Mitsuo and Fukuda, Nobuyuki and Ueno, Hiroshi and Kinugawa, Koichiro},
title = {Prognostic Impact of Psoas Muscle Mass Index following Trans-Catheter Aortic Valve Replacement},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {12},
pages = {3943},
doi = {10.3390/jcm12123943}
}
EUVIMED